NumerixS Investment Technologies’s PDL BioPharma, Inc. PDLI Stock Holding History

NumerixS Investment Technologies’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-24,615	Closed	-$52K	–	1509
2016 Q4	$52K	Sell	24,615 -68,100	-73%	-$190K	0.01%	962
2016 Q3	$311K	Sell	92,715 -40,000	-30%	-$127K	0.04%	534
2016 Q2	$417K	Sell	132,715 -12,900	-9%	-$43K	0.06%	467
2016 Q1	$485K	Sell	145,615 -20,300	-12%	-$63.3K	0.06%	474
2015 Q4	$587K	Buy	165,915 +70,080	+73%	+$293K	0.07%	369
2015 Q3	$482K	Buy	95,835 +38,100	+66%	+$218K	0.06%	399
2015 Q2	$371K	Buy	57,735 +17,035	+42%	+$114K	0.05%	453
2015 Q1	$286K	Buy	40,700 +7,779	+24%	+$56.3K	0.05%	454
2014 Q4	$254K	Buy	+32,921	New	+$261K	0.09%	355

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

NumerixS Investment Technologies's PDLI Position: Q1 2017 in Review

NumerixS Investment Technologies sold out of PDL BioPharma, Inc. (PDLI) in Q1 2017, closing a stake of 24,615 shares — an estimated $52K sold.

NumerixS Investment Technologies first reported a position in PDLI in Q4 2014 and held it in 9 quarters. The position peaked at $587K in Q4 2015. 174 funds tracked by Wall St. Rank hold PDLI as of Q1 2017.

NumerixS Investment Technologies reported no remaining PDL BioPharma, Inc. position as of Q1 2017 after selling out during the quarter.
NumerixS Investment Technologies sold 24,615 PDL BioPharma, Inc. shares in Q1 2017, an estimated $52K.
NumerixS Investment Technologies first reported a position in PDL BioPharma, Inc. in Q4 2014 and held it in 9 quarters.
NumerixS Investment Technologies's PDL BioPharma, Inc. position peaked at $587K in Q4 2015.
174 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2017.

Based on NumerixS Investment Technologies's 13F filing for Q1 2017, filed 15 May 2017.